Recent advances in bacteria‐based platforms for inflammatory bowel diseases treatment

J Lu, X Shen, H Li, J Du - Exploration, 2024 - Wiley Online Library
Inflammatory bowel disease (IBD) is a recurring chronic inflammatory disease. Current
treatment strategies are aimed at alleviating clinical symptoms and are associated with …

Nanotechnology-based in situ cancer vaccines: Mechanisms, design, and recent advances

G Niu, H Wang, Y Zhai, B Zhou, Y Kang, Z Pei, X Ji - Nano Today, 2024 - Elsevier
In recent years, in situ cancer vaccines, as an emerging cancer immunotherapy strategy,
have garnered considerable attention. This review comprehensively discusses the research …

Supramolecular Lipid Nanoparticles Based on Host–Guest Recognition: A New Generation Delivery System of mRNA Vaccines For Cancer Immunotherapy

S Qi, X Zhang, X Yu, L Jin, K Yang, Y Wang… - Advanced …, 2024 - Wiley Online Library
Dendritic cell (DC) maturation is a crucial process for antigen presentation and the initiation
of T cell‐mediated immune responses. Toll‐like receptors play pivotal roles in stimulating …

[HTML][HTML] Microenvironment-responsive metal-phenolic network release platform with ROS scavenging, anti-pyroptosis, and ECM regeneration for intervertebral disc …

H Zhou, J He, R Liu, J Cheng, Y Yuan, W Mao, J Zhou… - Bioactive Materials, 2024 - Elsevier
Intervertebral disc degeneration (IVDD) can be caused by aging, injury, and genetic factors.
The pathological changes associated with IVDD include the excessive accumulation of …

On the role of nanocarriers in oral drug delivery

Q Yu, W Wu - Therapeutic Delivery, 2023 - Taylor & Francis
The oral route is most favorable for drug delivery because of easy manufacturing and
handling, less strict regulatory requirements, fewer safety concerns and high patient …

Oral biomimetic virus vaccine hydrogel for robust abscopal antitumour efficacy

C Wang, H Tang, Q Zhang, W Shan, X Wang… - Journal of Colloid and …, 2024 - Elsevier
Remarkable progress has been made in tumour immunotherapy in recent decades.
However, the clinical outcomes of therapeutic interventions remain unpredictable, largely …

[HTML][HTML] Nanodrug delivery materials for digestive system diseases

D Yang, H Zeng, Y Zhuang, S Jiang, W Pan - APL Materials, 2024 - pubs.aip.org
Digestive system diseases, such as gastritis, gastric ulcers, chronic liver disease,
inflammatory bowel disease (IBD), and colorectal cancer, represent a major group of …

[HTML][HTML] Transepithelial transport of nanoparticles in oral drug delivery: From the perspective of surface and holistic property modulation

Y Zheng, S Luo, M Xu, Q He, J Xie, J Wu… - … Pharmaceutica Sinica B, 2024 - Elsevier
Despite the promising prospects of nanoparticles in oral drug delivery, the process of oral
administration involves a complex transportation pathway that includes cellular uptake …